CME Group Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
CME Group Stock Forecast and Price Target
In recent months, two notable analysts have provided yearlong price targets for CME Group, with the average target coming in at $226.00. If it were to be achieved, this would result in a potential upside of approximately 8.48 percent from the most recent closing price in May, 2024. The high end is $250.00, and the low is $187.00. Although you may not be interested in CME stock, you should still be aware of its competitors.
8.48% Upside
CME Group Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, CME Group's Price has decreased from $181.84 to $0.00 – a 100.00% drop! For the next year, analysts predict that Fair Value will reach $240.83 – an increase of 100.00%. Over the next seven years, experts believe that CME Group's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MS Stock Forecast | Morgan Stanley | Outperform |
8
|
$95.79 | Buy/Sell | $95.04 | -0.82% |
| GS Stock Forecast | The Goldman Sachs Group | Outperform |
5
|
$443.80 | Buy/Sell | $414.18 | 1.40% |
| SPGI Stock Forecast | S&P Global Inc | Buy |
10
|
$428.56 | Buy/Sell | $484.43 | 16.67% |
| FI Stock Forecast | Fiserv | Outperform |
10
|
$153.04 | Buy/Sell | $150.93 | 12.39% |
| ICE Stock Forecast | Intercontinental Exchange | Outperform |
11
|
$133.72 | Buy/Sell | $148.36 | 12.92% |
CME Group Revenue Forecast for 2023 - 2025 - 2030
In the last three years, CME Group's Revenue has grown by 14.35%, rising from $4.87B to $5.57B. For the next year, analysts predict that Revenue will reach $5.60B – an increase of 0.57%. Over the next seven years, experts believe that CME Group's Revenue will grow at a rate of 11.80%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TRI Stock Forecast | Thomson Reuters | Hold |
7
|
C$229.08 | Buy/Sell | C$118.78 | -26.62% |
| MCO Stock Forecast | Moody's | Outperform |
8
|
$393.97 | Buy/Sell | $393.47 | 4.70% |
| LSEG Stock Forecast | London Stock Exchange Group | Outperform |
10
|
£93.08 | Buy/Sell | £97.65 | 14.95% |
.jpg)
CME Group Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, CME Group's Dividend per Share has grown, moving from $3.40 to $4.40 – an increase of 29.41%. In the next year, analysts predict that Dividend per Share will jump to $8.33 – up 89.32% from the current level. Looking ahead to seven years, experts forecast that Dividend per Share will grow by 111.48%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 388 Stock Forecast | Hong Kong Exchanges and Cleari... | Outperform |
17
|
HK$266.00 | Buy/Sell | HK$352.49 | 10.53% |
| FIS Stock Forecast | Fidelity National Information ... | Outperform |
17
|
$74.31 | Buy/Sell | $69.28 | 7.66% |
| MSCI Stock Forecast | MSCI | Outperform |
12
|
$471.40 | Buy/Sell | $621.39 | 14.55% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WKL Stock Forecast | Wolters Kluwer N.V. | Outperform |
5
|
146.00€ | Buy/Sell | 125.83€ | 6.85% |
| DB1 Stock Forecast | Deutsche Börse | Outperform |
9
|
187.05€ | Buy/Sell | 194.24€ | 8.53% |
| VRSK Stock Forecast | Verisk Analytics | Outperform |
18
|
$247.00 | Buy/Sell | $250.89 | 4.25% |
CME Group EBITDA Forecast for 2023 - 2025 - 2030
CME Group's EBITDA has seen growth In the last three years, going from $3.14B to $3.81B – a gain of 21.45% In the next year, analysts believe that EBITDA will reach $4.07B – an increase of 6.90%. For the next seven years, the forecast is forEBITDA to grow by 23.51%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IT Stock Forecast | Gartner | Outperform |
6
|
$437.13 | Buy/Sell | $466.70 | 7.52% |
| BR Stock Forecast | Broadridge Financial Solutions | Hold |
18
|
$201.36 | Buy/Sell | $208.09 | 2.00% |
| TW Stock Forecast | Tradeweb Markets | Outperform |
14
|
$110.38 | Buy/Sell | $102.13 | 6.90% |
CME Group EBIT Forecast for 2023 - 2025 - 2030
In the last three years, EBIT for CME Group has grown by 29.36%, going from $2.67B to $3.46B. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $3.87B – an increase of 11.81%. Over the next seven years, experts anticipate that EBIT growth for CME Group will be 31.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FDS Stock Forecast | FactSet Research Systems | Hold |
16
|
$435.46 | Buy/Sell | $430.46 | 6.09% |
| 8697 Stock Forecast | Japan Exchange Group | Hold |
18
|
¥3.87k | Buy/Sell | ¥2.86k | -30.10% |
| ENX Stock Forecast | Euronext N.V. | Outperform |
18
|
85.35€ | Buy/Sell | 88.00€ | 13.47% |
CME Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, CME Group's EPS has decreased from $6.72 to $0.00 – a 100.00% drop! For the next year, analysts predict that EPS will reach $8.90 – an increase of 100.00%. Over the next seven years, experts believe that CME Group's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PSON Stock Forecast | Pearson | Outperform |
18
|
£9.98 | Buy/Sell | £11.27 | 13.23% |
| X Stock Forecast | TMX Group | Hold |
18
|
C$36.86 | Buy/Sell | C$33.88 | 5.81% |
| S68 Stock Forecast | Singapore Exchange | Hold |
18
|
$9.25 | Buy/Sell | $10.16 | 8.11% |
.jpg)